|
|
| Research article summary (published 30 May 2009): |
Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer.
Full Abstract
BACKGROUND: The authors elucidated particular chemokine receptors that are expressed on lung cancer cells, as well as the clinical significance of the expression of these chemokine receptors in completely resected nonsmall cell lung cancer (NSCLC). METHODS: The authors examined gene expression of chemokine receptors (CCR1-11, CXCR1-7, XCR1, and CX3CR1) in 11 cell lines of lung cancer, and gene expression of CXCR3, CXCR4, and CXCR7 (CXCR3/4/7) in surgical specimens of 127 patients who underwent complete resection for their NSCLC between May 2001 and December 2002, using quantitative real-time reverse transcriptase-polymerase chain reaction (PCR). Mutation detection analysis of the EGFR genes using the PCR single-strand conformational polymorphism method was evaluated in patients with pathological (p-) stage I adenocarcinoma. RESULTS: Substantial expression of CXCR3/4/7 mRNA was observed in all NSCLC cell lines examined. In p-stage I NSCLC, CXCR4 and CXCR7 expression values in patients with postoperative metastatic recurrence (Rec-Distant) were significantly higher than in those without recurrences (P = .003 and P = .007, respectively). In addition, the 5-year disease-free survival (DFS) rate of high CXCR7-expressing patients (63.2%) was significantly lower than that of low CXCR7-expressing patients (84.8%) (P = .033). The EGFR mutation was significantly more frequent in patients with higher CXCR7 expression (14 of 21 patients) than in those with lower CXCR7 expression (12 of 32 patients) (P = .038). A multivariate analysis confirmed that high CXCR7 expression was an independent and significant factor predicting a poor DFS in p-stage I NSCLC patients (P = .041). CONCLUSIONS: Higher expression of CXCR7 is associated with Rec-Distant and poor DFS in patients with p-stage I NSCLC. (c) 2009 American Cancer Society.
Author information
Author/s: Iwakiri, Shotaro (S); Mino, Nobuya (N); Takahashi, Tsuyoshi (T); Sonobe, Makoto (M); Nagai, Shinjiro (S); Okubo, Kenichi (K); Wada, Hiromi (H); Date, Hiroshi (H); Miyahara, Ryo (R);
Affiliation: Department of Thoracic Surgery, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.
Journal and publication information
Publication Type: Journal Article
Journal: Cancer (Cancer), published in United States. (Language: eng)
Reference: 2009-Jun; vol 115 (issue 11) : pp 2580-93
Dates: Created 2009/05/25; Completed 2009/07/16;
PMID: 19309748, status: MEDLINE (last retrieval date: 7/25/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
30 May 2000 - Targeting targeted therapy.
27 Apr 2004 - EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
27 Apr 2004 - Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.
30 Dec 2006 - Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
30 Jul 2007 - Prognosis of the surgical treatment of patients with non-small cell lung cancer (NSCLC)--relation to DNA ploidy.
30 May 2003 - Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor.
13 Dec 2007 - Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer.
18 Nov 2001 - Cancer. A bull's eye for targeted lung cancer therapy.
2 Jun 2004 - Erlotinib in lung cancer - molecular and clinical predictors of outcome.
12 Jul 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.